186 related articles for article (PubMed ID: 36848266)
21. Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
Nooka AK; Behera M; Lonial S; Dixon MD; Ramalingam SS; Pentz RD
Cancer; 2016 Oct; 122(20):3207-3214. PubMed ID: 27404488
[TBL] [Abstract][Full Text] [Related]
22. Underrepresentation of Women in Reduced Ejection Heart Failure Clinical Trials With Improved Mortality or Hospitalization.
Ekpo E; Balla S; Ngo S; Witting C; Sarraju A; Furst A; Rodriguez F
JACC Adv; 2024 Jan; 3(1):. PubMed ID: 38405270
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of trends in the representation of patients by age, sex, and diverse race/ethnic groups in bladder and kidney cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Stewart TF; Kader AK; Derweesh I; Martinez ME; Rose BS
Urol Oncol; 2022 May; 40(5):199.e15-199.e21. PubMed ID: 35431133
[TBL] [Abstract][Full Text] [Related]
24. Racial and ethnic underrepresentation in dermatology clinical trials.
Mineroff J; Nguyen JK; Jagdeo J
J Am Acad Dermatol; 2023 Aug; 89(2):293-300. PubMed ID: 37062462
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
[TBL] [Abstract][Full Text] [Related]
26. Enrollment of female participants in United States drug and device phase 1-3 clinical trials between 2016 and 2019.
Sosinsky AZ; Rich-Edwards JW; Wiley A; Wright K; Spagnolo PA; Joffe H
Contemp Clin Trials; 2022 Apr; 115():106718. PubMed ID: 35247632
[TBL] [Abstract][Full Text] [Related]
27. Under-reporting and under-representation of non-Hispanic Black subjects in lipid-lowering atherosclerotic cardiovascular disease outcomes trials: A systematic review.
Grant JK; Dangl M; Koester M; Tegegn M; Knijnik L; Singh H; Orringer CE
J Clin Lipidol; 2022; 16(5):608-616. PubMed ID: 36089503
[TBL] [Abstract][Full Text] [Related]
28. The Representation of Surgery in Oncology Clinical Trials: 2001 to 2022.
Shah R; Boffa D; Khan S; Judson B
Ann Surg Oncol; 2023 Nov; 30(12):7275-7280. PubMed ID: 37556010
[TBL] [Abstract][Full Text] [Related]
29. Demographic recruitment bias of adults in United States randomized clinical trials by disease categories between 2008 to 2019: a systematic review and meta-analysis.
Buffenstein I; Kaneakua B; Taylor E; Matsunaga M; Choi SY; Carrazana E; Viereck J; Liow KK; Ghaffari-Rafi A
Sci Rep; 2023 Jan; 13(1):42. PubMed ID: 36593228
[TBL] [Abstract][Full Text] [Related]
30. Representation of Women in Contemporary Kidney Transplant Trials.
Vinson AJ; Ahmed SB
Transpl Int; 2023; 36():11206. PubMed ID: 37125385
[TBL] [Abstract][Full Text] [Related]
31. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
[TBL] [Abstract][Full Text] [Related]
33. Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.
Jin X; Chandramouli C; Allocco B; Gong E; Lam CSP; Yan LL
Circulation; 2020 Feb; 141(7):540-548. PubMed ID: 32065763
[TBL] [Abstract][Full Text] [Related]
34. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
Loree JM; Anand S; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K
JAMA Oncol; 2019 Oct; 5(10):e191870. PubMed ID: 31415071
[TBL] [Abstract][Full Text] [Related]
35. Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials.
Muir R; Jacobs JW; Flores LE; Marshall AL; Ansari ES; Booth GS; Silver JK
Transfus Apher Sci; 2023 Jun; 62(3):103653. PubMed ID: 36781328
[TBL] [Abstract][Full Text] [Related]
36. Race and Ethnicity Reporting and Representation in Obstetrics and Gynecology Clinical Trials and Publications From 2007-2020.
Steinberg JR; Turner BE; DiTosto JD; Weeks BT; Young AMP; Lu CF; Wolgemuth T; Holder K; Laasiri N; Squires N; Zhang N; Richardson MT; Magnani CJ; Anderson JN; Roque DR; Yee LM
JAMA Surg; 2023 Feb; 158(2):181-190. PubMed ID: 36542396
[TBL] [Abstract][Full Text] [Related]
37. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
Rees CA; Pica N; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
[TBL] [Abstract][Full Text] [Related]
38. Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis.
Addeo A; Weiss GJ; Gyawali B
JAMA Netw Open; 2019 May; 2(5):e193684. PubMed ID: 31074821
[TBL] [Abstract][Full Text] [Related]
39. Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
Hutchins LF; Unger JM; Crowley JJ; Coltman CA; Albain KS
N Engl J Med; 1999 Dec; 341(27):2061-7. PubMed ID: 10615079
[TBL] [Abstract][Full Text] [Related]
40. Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period.
Holliday EB; Ahmed AA; Yoo SK; Jagsi R; Hoffman KE
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):721-31. PubMed ID: 26104927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
